Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
Max Hodak, the former president and co-founder of Neuralink, detailed on stage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on techcrunch.com — the content belongs to TechCrunch.
